Wai Chun Bio-Technology Investor Relations Material
Latest events
H1 2025
27 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Wai Chun Bio-Technology Limited
Access all reports
Wai Chun Bio-Technology Limited is a Hong Kong-based investment holding company engaged in the trading and distribution of modified starch and other biochemical products. The company’s operations include sourcing, processing, and selling agricultural and industrial-grade starch products used in food processing, paper manufacturing, textiles, and other industrial applications. Wai Chun Bio-Technology also explores opportunities in related sectors to diversify its business portfolio. The company is headquartered in Hong Kong, and its shares are listed on the HKEX.
Latest articles
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
Ticker symbol
660
Country
🇭🇰 Hong Kong